Zura Bio Limited
ZURA
$1.99
$0.2413.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.61% | -6.12% | 13.18% | 32.61% | 44.69% |
| Total Depreciation and Amortization | 2,700.00% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 115.77% | -38.83% | -45.23% | -61.75% | -79.49% |
| Change in Net Operating Assets | -76.93% | 12.67% | -54.91% | -3.66% | 153.66% |
| Cash from Operations | -139.09% | -103.57% | -86.50% | -98.75% | -99.65% |
| Capital Expenditure | -617.65% | -1,571.43% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | 37.50% | 68.93% | 47.62% |
| Cash from Investing | 98.32% | 99.10% | 36.56% | 68.74% | 47.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -82.19% | 15.00% | -43.50% | -43.50% | -48.25% |
| Repurchase of Common Stock | -1,500.00% | -1,345.45% | -1,345.45% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.65% | 256.81% | 293.08% | 434.72% | 231.09% |
| Cash from Financing | -90.37% | 52.07% | -9.44% | -13.36% | -23.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -144.89% | 76.11% | -21.93% | -16.43% | -30.31% |